Meet Sentante’s CEO Edvardas Satkauskas | Interview by Joe Mullings
Joe Mullings sits down with Edvardas Satkauskas, CEO of Sentante, to discuss the company’s groundbreaking work in robotic surgery and the future of MedTech.
June 20, 2025
Sensory,
Teleoperated,
Intuitive
Teleoperated,
Intuitive
The first fully-robotic
teleoperated system
for endovascular interventions
Sentante
Endovascular procedures performed remotely with uncompromised feedback force
View Video
3:00
Sentante enables the remote manipulation of catheters and guidewires
for safe and rapid endovascular disease management
Remote interventions reduce the response time for
stroke, heart attack
and bleeding
Uniqueness
of Sentante:
of Sentante:
Disruptive technology:
01
Fully robotic
The manipulation of three endovascular instruments simultaneously allows the entire procedure to be performed robotically.
02
Teleoperated
The endovascular procedure can be performed from a different room or hospital.
03
Haptic feedback
Physicians can feel the catheter and guidewire just as if they were standing near the patient
04
Universal compatibility
A variety of dedicated catheters and guidewires are compatible, with no dependence on the manufacturer
05
Precise manipulation
Accurate, submillimetric instrument positioning and stent placement
06
Ergonomic workplace
Allows physicians to fully concentrate on an ongoing case without the use of heavy lead aprons
07
No additional training is needed
Physicians interface with the robot is via the same endovascular instruments as in a manual procedure
08
Occupational hazards free
Medical personnel are not exposed to hazardous X-rays
Future
perspectives
perspectives
01
Training module
Realistic training platform with haptic feedback for residents and new physicians
02
Device testing platform
Simulated models for safe, affordable testing and training of endovascular devices
03
Artificial intelligence based automation
Semi-automated routine tasks such as catheter or guidewire exchange
About Us
Our vision is to transform healthcare by increasing treatment availability for patients and protecting medical personnel from occupational hazard. Our mission is to bring the world’s first fully-robotic system for endovascular interventions to clinical practice for the benefit of patients, physicians, and hospitals.
Our values People focused. We care about patients, medical personnel, and colleagues. Result-based. We are bringing only evidence-based, new medical solutions to the hospitals.
Innovation driven. Constant research and development of the novel medical solutions. Sustainability in mind. Trying not to destroy the planet while supplying the most advanced healthcare solutions.
Our vision is to transform healthcare by increasing treatment availability for patients and protecting medical personnel from occupational hazard. Our mission is to bring the world’s first fully-robotic system for endovascular interventions to clinical practice for the benefit of patients, physicians, and hospitals.
Our values People focused. We care about patients, medical personnel, and colleagues. Result-based. We are bringing only evidence-based, new medical solutions to the hospitals.
Innovation driven. Constant research and development of the novel medical solutions. Sustainability in mind. Trying not to destroy the planet while supplying the most advanced healthcare solutions.
Management Team
Edvardas Satkauskas
CEO
Experienced entrepreneur, Co-founder of Inovatyvi Medicina
Dr. Tomas Baltrūnas
CMO
Vascular surgeon, Founder of Inovatyvi Medicina
Perry Van Rijsingen
Board Member
Dr. Evaldas Kalvaitis
COO
Co-founder of Inovatyvi Medicina
Vilius Dambrauskas
CTO
Co-founder of Inovatyvi Medicina
Vaidas Labunskas
Chief Mechanical Engineer
Co-founder of Inovatyvi Medicina
Ugnė Gurskė
Human Resources Manager
Advisory Board Members
Dr. Ricardo A. Hanel
Medical Advisory Board Member
![bandymas4[4382]](https://sentante.com/wp-content/uploads/elementor/thumbs/bandymas44382-q4uru2vgjr8kaa9e5haw4af639rkgxg1vvurfx2xi8.png "bandymas4[4382]")
Dr. Michael Lichtenberg
Medical Advisory Board Member
![David-Liebeskind[4385]](https://sentante.com/wp-content/uploads/elementor/thumbs/David-Liebeskind4385-q4usqcnz6zeywbdtpfhrq58wbip8qtkabm6wlx8bvk.png "David-Liebeskind[4385]")
Dr. David Liebeskind
Medical Advisory Board Member
![Giovanni-gera[4434]](https://sentante.com/wp-content/uploads/elementor/thumbs/Giovanni-gera4434-q4uw1a6txc81w4mo8c7epmti5mi5o4pn09rllaw2lc.png "Giovanni-gera[4434]")
Dr. Giovanni Torsello
Medical Advisory Board Member
![Peter-Shneider[4388]](https://sentante.com/wp-content/uploads/elementor/thumbs/Peter-Shneider4388-q4ussc3pme4reoi24adezn7xgsx4ztfvxfrt2yaeqo.png "Peter-Shneider[4388]")
Dr. Peter Schneider
Medical Advisory Board Member
Matt Lemay
Business Advisory Board Member
Christopher Prentice
Business Advisory Board Member
Route to
market
market
Expecting launch in 2025
01
Inovatyvi Medicina established
Sentante development began
02
First grant received
Lithuanian Business support agency
01
Hard, dedicated work
TRL4 reached
02
H2020 SME phI grant
Awarded a highly competitive grant
03
Perfect New Year’s party
A solid kickstart into 2019
01
First animal test
Proved to manipulate guidewires perfectly
02
TRL4 reached
Positive feedback from physicians
01
Ongoing animal tests
Again, proved to manipulate guidewires and catheters perfectly
02
TRL5 reached
03
First patent application
EPO
01
TRL6 reached
02
Successful stent implantation
Both Rx and OTW
03
First patent application
01
Work in progress
01
Pre-clinical animal testing
02
Continuing patent applications
01
First use of the Sentante robotic system in human patients
News
First fully robotic remote endovascular stroke thrombectomy!
🚀 A historic milestone in neurointervention! We’ve just performed the first fully robotic remote endovascular stroke thrombectomy in an animal model using the Sentante robot
June 13, 2025
Exploring the Future of Digital Cath Labs
Sentante is more than a robotic solution – it’s the key to unlocking the fully digitalized cath lab of the future. By collecting real-time data
April 2, 2025
iF Design Award 2025!
🏆 𝐁𝐈𝐆 𝐖𝐈𝐍! 𝐒𝐞𝐧𝐭𝐚𝐧𝐭𝐞 has been recognized with an 𝐢𝐅 𝐃𝐞𝐬𝐢𝐠𝐧 𝐀𝐰𝐚𝐫𝐝 𝟐𝟎𝟐𝟓! ✨Out of 10,651 submissions across 82 categories, our work on Sentante stood out,
March 1, 2025
New Bussiness Advisory Board Member – Marvin Slosman
We are thrilled to welcome Marvin Slosman to our Business Advisory Board!With his expertise in commercialization and financial strategy, he will be instrumental in driving
February 24, 2025
Sentante on stage! LINC2025
Thousands of interventional specialists, vascular experts, and healthcare professionals from around the world gathered in Leipzig to engage in cutting-edge discussions, groundbreaking presentations, and hands-on learning experiences. 🔥 Sentante’s
January 30, 2025
Haptic Feedback Meets Robotic Precision
With Sentante, we’ve created an interface where haptics finally make sense -bringing the feel of manual control into minimally invasive procedures. Sentante isn’t just about
December 9, 2024
VEITH Symposium 2024
We were proud to showcase Sentante at this year’s VEITHsymposium, giving attendees a hands-on opportunity to experience our 1:1 haptic feedback – a game-changer in
November 27, 2024
Sentante’s debut at Houson Methodist’s
Sentante‘s debut at Houston Methodist’s advanced technology facility was an exciting moment! The inspiring feedback we’ve received about our system’s capabilities and ease of adoption highlights
November 15, 2024
Successful Human Trial Completed!
The Sentante Endovascular Robotic System has hit a major milestone, completing its first in human clinical study led by Dainis Krievins, MD, PhD in Riga,
August 23, 2024